SlideShare a Scribd company logo
Inflammation
Acute
inflammation
Inflammation
 Describe the causes and mechanisms of
acute and chronic inflammation
 Describe the chemical mediators of
inflammation
 Understand the systemic effects of
inflammation
Inflammation
local physiological response to tissue injury
Not a disease, usu a manifestation of d’se
beneficial effects:
 destruction of invading microorganisms
 walling off of an abscess cavity
Prevent spread of infection
Inflammation
produce disease
abscess in the brain: SOL
Compress vital surrounding structure
 fibrosis from CI may distort the tissues
permanently alter their function
purpose to localize and eliminate the
causative agent
 limit tissue injury and restore tissue to normality
Inflammation
classified according to its time course as:
 acute inflammation
 chronic inflammation
Causes of acute inflammation
 physical agents, e.g. trauma, heat, cold,
ultraviolet light, radiation
 irritant and corrosive chemical subst, e.g. acids,
alkalis
 Biological agents, e.g. pyogenic bacteria
 immune-mediated hypersensitivity reactions, e.g.
immune-mediated vasculitis, seasonal allergic
rhinitis (hay fever)
 Endogenous causes:
 tissue necrosis, e.g. ischaemia resulting
in a myocardial infarction
 Circulation disorders: thrombosis,
infarction, hemorrhage
 Enzymes activation – e.g. acute
pancreatitis
 Metabolic products deposals – uric acid,
urea
Causes of acute inflammation
Cardinal signs
essential physical characteristics of AI
formulated by Celsus
30 BC to AD 38 using the Latin words
 rubor, calor, tumor and dolor
rubor (redness)
tumor (swelling)
calor (heat)
dolor (pain)
 functio laesa, or loss of function
 second century AD: Greek physician Galen
are produced by a rapid vascular
response and cellular events
characteristic of AI
main function of these events is to
bring elements of the immune system
to the site of injury
prevent further tissue damage
Cardinal Signs
Early stages of AI
In the early stages, oedema fluid, fibrin
and neutrophil polymorphs accumulate in
the extracellular spaces of the damaged
tissue
 presence of the cellular component: the
neutrophil polymorph
essential for a histological diagnosis
AI response involves three processes:
Vascular response
1. changes in vessel calibre:
2. increased vascular permeability and
formation of the fluid exudate
Cellular events
3. formation of the cellular exudate –
emigration of the neutrophil polymorphs into
the extravascular space
Early stages of AI
Vascular response
Vasodilatation
 BF to the capillary bed is normally limited
by the precapillary sphincters
 In AI vasodilatation occurs when the
arterioles and precapillary sphincters
relax
results in increased blood flow to the
injured area
Increased vascular permeability
 Endothelial intracellular proteins contract
under the influence of chemical
inflammatory mediators:
 histamine, bradykinin, nitric oxide, C5a
leukotriene B4 and platelet activating factor
Endothelial contraction results in:
increased fenestrations between endothelial
cells
increased permeability of vessels to plasma
proteins
Vascular response
Increased vascular permeability
Proteins leak out of the plasma into the
interstitial spaces
 includes circulating components: immunoglobulins and
coagulation factors
 decreases in the plasma oncotic pressure
 escape of plasma proteins into interstitial S
increases the colloid osmotic pressure there
The Vascular Response
 Phase I = vasoconstriction
 momentary constriction of small blood vessels in
the area
 Vascular spasm begins very quickly (30 sec.)
after the injury at it last a few minutes
 mechanism of spasm is nervous – thru
catecholamine liberated from sympatic nerves
endings
The Vascular Response
 Phase II = active vasodilation
 thru catabolism products that act thru receptors and
directly stimulates vascular dilation – nervous
mechanism
 Dilation of arterioles and capillaries (redness =
rubor)
 Blood flow increases and gives pulsate sensation
 Active hyperemia in skin territory and increased
metabolism leads to higher local temperature (heat =
calor)
The Vascular Response
 Phase III = passive vasodilation
 Blood vessels in the affected area loose their
reactivity to nervous and humoral stimuli and
passive vasodilation occurs
 Progressively fluid move into the tissues (increased
vascular permeability and structural alteration of
blood vessels) and cause swelling (tumor), pain,
and impaired function
The Vascular Response
 Phase III = passive vasodilation
 exudation of the fluid out of the capillaries and into
the tissue spaces dilutes the offending agent
 As fluid moves out of the capillaries, stagnation of
flow and clotting of blood in the small capillaries
occurs at the site of injury
 This aids in localizing the spread of infectious
microorganisms
Inflammatory oedema
capillary hydrostatic pressure increased
much more fluid leaves the vessels than is
returned to them
 net escape of protein-rich fluid is called
exudation
 called the fluid exudate
combined increase in hydrostatic
pressure and the decreased oncotic
pressure (from leakage of proteins into
ECS) causes net fluid movement from
plasma into tissues
this is inflammatory oedema
Inflammatory oedema
Advantages of I oedema
Fluid increase in the damaged tissue dilutes
and modifies the action of toxins
Protein levels increase in the tissue—these
include protective antibodies and fibrin
Non-specific antibodies act as opsonins for
neutrophil mediated phagocytosis and
function to neutralize toxins
If the antigen is coated with antibody or
complement, its adherence is increased
because of binding to complement
This process of enhanced binding of an
antigen caused by antibody or complement
is called opsonization
Advantages of I oedema
Phagocytosis
Advantages of I oedema
formation of a fibrin net acts as a scaffold for
inflammatory cells
 prevent the spread of microorganisms
Circulation of the exudate into the lymphatic
system assists in antigen presentation
 helps mount a specific immune response
Cellular events
Formation of the cellular exudate
 accumulation of neutrophils within the ECS
diagnostic histological feature of AI
 Neutrophils pass between endothelial cell
junctions and invade damaged tissue to
combat the effects of injury
 The movement of leucocytes out of the vessel
lumen is termed extravasation
Extravasation
achieved in five stages
1. Margination to the plasmatic zone
This is assisted by the slowing of the blood
2. ‘Rolling’ of leucocytes due to the repeated
formation and destruction of transient
adhesions with the endothelium
3. Adhesion: ‘pavementing’—leucocytes
eventually firmly adhere to the endothelium
due to the interaction of paired molecules on the
leucocyte and endothelial cell surface, e.g. β2-
integrin and ICAM-1
4. Transmigration: diapedesis—leucocytes pass
between the endothelial cell junctions, through
the vessel wall into tissue spaces
Extravasation
5. Chemotaxis—
After exiting the circulation, neutrophils move
in the tissues toward the site of injury by a
process called chemotaxis
neutrophils migrate are possibly activated by
chemical substances: chemotaxins
released at sites of tissue injury
thought to be leukotrienes, complement
components and bacterial products
Extravasation
 Steps in neutrophil emigration
 Neutrophils
 (1) marginate into the plasmatic
zone
 (2) adhere to endothelial cells
 (3) pass between endothelial
cells
 (4) pass through the basal
lamina and migrate into the
adventitia
Phagocytosis and intracellular killing
predominant cell type of AI is the
neutrophil
Lymphocytes, plasma cells and MØs
are the cells found in CI
Neutrophils and monocytes ingest debris
and foreign particles at the site Cellular
pseudopodia engulf the foreign particle and
fuse
 phagocytic vacuole or phagosome
Phagocytosis is assisted by opsonization
with immunoglobulins and complement
components
Phagocytosis and intracellular killing
 Phagocytosis of foreign particle by leucocyte
 (A) Attachment of foreign particle
 (B) Pseudopodia engulfing particle
 (C) and (D) Incorporation within the cell in a
vacuole: phagosome
Following phagocytosis, leucocytes attempt to
destroy phagocytosed material:
 discharge of lysosomal enzymes into the
phagosome
 oxygen-dependent mechanisms:
H2O2, O2−, •OH
 oxygen-independent mechanisms:
lactoferrin, lysozyme and hydrolases
Phagocytosis and intracellular killing
 actions of neutrophils in
AI process
 events mediated by:
 Selectins
 ICAM-1: intercellular
adhesion molecule 1
 CD31
 C5a and leukotriene B4
 C3b and IgG
 Myeloperoxidase,
lysozyme
Chemical mediators of inflammation
Several different inflammatory mediator
systems interact to produce inflammation
No chemical mediator alone can be entirely
responsible for any single feature of the IR
Regulatory mechanisms exist in all mediator
systems
Chemical mediators of inflammation
chemicals called endogenous chemical
mediators, cause:
 vasodilatation
 emigration of neutrophils
 chemotaxis
 increased vascular permeability
 itching and pain
Endogenous chemical mediators of the acute IR
TNF-a and IL-1 are responsible for
 fever and the release of stress hormones
norepinephrine, vasopressin, activation of the
renin-angiotensin-aldosterone system
 synthesis of IL-6, IL-8, and interferon gamma
Cytokines, esp IL-6, stimulate the release of
acute-phase reactants such as C-reactive protein
(CRP)
Chemical mediators of inflammation
The proinflammatory interleukins
either function directly on tissue
work via secondary mediators to activate:
 the coagulation cascade
 complement cascade
 the release of nitric oxide, platelet-activating
factor, prostaglandins, and leukotrienes
Chemical mediators of inflammation
 Complement fragments and cytokines
 stimulates chemotaxis of neutrophils, eosinophils
and monocytes
 C3a, C5a increase vascular permeability;
 Cytokines
 Interleukins (IL1, IL 6, IL8)
Stimulates the chemotaxis, degranulation of
neutrophils and their phagocytic activity
Induce extravascularization of granulocytes
Fever
 Tumor necrosis factor (TNF) and IL 8
Leukocytosis
Fever
Stimulates prostaglandins production
Chemical mediators of inflammation
Prostaglandins
lipid soluble molecules derived from
arachidonic acid, a fatty acid liberated from
cell membrane phospholipids, through the
cyclooxygenase pathway
contribute to vasodilation, capillary
permeability, and the pain and fever that
accompany inflammation
Chemical mediators of inflammation
Stable prostaglandins: PGE1 and PGE2
induce inflammation
potentiate the effects of histamine and other
inflammatory mediators:
cause the dilation of precapillary arterioles
lower the blood pressure
modulates receptors activity
affect the phagocytic activity of WBC
prostaglandin thromboxane A2 promotes
platelet aggregation and vasoconstriction
Chemical mediators of inflammation
Leukotrienes
are formed from arachidonic acid
thru the lipoxygenase pathway
Histamine and leukotrienes are
complementary in action
Histamine is produced rapidly and transiently
while the more potent leukotrienes are being
synthesized
Chemical mediators of inflammation
Leukotrienes
 C4 and D4 are recognized as the primary
components of the slow reacting substance of
anaphylaxis (SRS-A)
causes slow and sustained constriction of the
bronchioles
Leukotrienes affect
permeability of the postcapillary venules
adhesion properties of endothelial cells
stimulates the chemotaxis
extravascularization of neutrophils, eosinophils,
and monocytes
Chemical mediators of inflammation
cyclooxygenase and lipoxygenase pathways
Histamine
 found in high concn in platelets, basophils, and
mast cells
 Causes dilation and increased permeability of
capillaries:
causes dilatation of precapillary arterioles
contraction of endothelial cells
dilation of postcapillary venules
 It acts through H1 receptors
Chemical mediators of inflammation
Platelet-activating factor (PAF)
 generated from a lipid complex stored in cell
membranes
 affects a variety of cell types and induces platelet
aggregation
 activates neutrophils and is a potent eosinophil
chemoattractant
 contributes to extravascularization of plasma
proteins and so, to edema
Chemical mediators of inflammation
Plasma Proteases: consist of:
 Kinins
Bradykinin - causes increased capillary
permeability: (implicated in hyperthermia and
redness) and pain
 Clotting factors
clotting system contributes to the vascular phase
of inflammation
mainly thru fibrin peptides that are formed during
the final steps of the clotting process
Chemical mediators of inflammation
Metabolic changes in inflammation
Protein metabolism
 Is increased – cell destruction, metabolic products
lead o increased osmotic pressure in interstitial space
which attracts water and contributes to edema
(swelling = tumor)
 metabolic changes: including skeletal muscle
catabolism, provide amino acids that can be used in
the immune response and for tissue repair
Glucose metabolism
 Anaerobe utilization of glucose is increased because
of hypoxia with increased formation of lactic and
pyruvic acid
Metabolic changes in inflammation
Lipid metabolism
 Increased formation of ketons and fatty acids
Mineral metabolism
 Increased extracellular K+ concentration
Acid – base balance
 Metabolic acidosis (ketons, lactic acid)
Systemic manifestations of inflammation
 IR remains confined to a localized area
 local injury can result in prominent systemic
manifestations
 inflammatory mediators are released into the
circulation
 most prominent systemic manifestations are:
 acute phase response
 Alterations in WBC count
 leukocytosis or leukopenia
 Fever
 Sepsis and septic shock: systemic inflammatory
response
 severe systemic manifestations of inflammation
The acute phase response
 Usually begins within hours or days of the onset of
inflammation or infection
 Includes:
 changes in the concns of plasma proteins - liver
dramatically increases the synthesis of acute-phase
proteins such as fibrinogen and C-reactive protein
 increased erythrocyte sedimentation rate
 fever
 increased numbers of leukocytes
 skeletal muscle catabolism
 negative nitrogen balance
The acute phase response
 responses are generated after the release of the
cytokines, IL-1, IL-6, and TNF:
 cytokines affect the thermoregulatory center in the
hypothalamus to produce fever
 IL-1 and other cytokines induce an increase in the
number and immaturity of circulating neutrophils by
stimulating their production in the bone marrow
 Lethargy
a common feature of the acute-phase response
results from the effects of IL-1 and TNF on the CNS
Outcomes of AI
 Resolution
 complete restoration of the inflamed tissue back to a
normal status
 Inflammatory measures such as vasodilation,
chemical production, and leukocyte infiltration cease,
and damaged parenchymal cells regenerate
 limited or short lived inflammation: usual outcome
 Fibrosis
 Large amounts of tissue destruction, or damage in
tissues unable to regenerate
 Fibrous scarring occurs in these areas of damage
 forming a scar composed primarily of collagen
scar will not contain any specialized structures
 parenchymal cells, hence functional impairment may occur
Outcomes
 Abscess formation
 A cavity is formed containing pus, an opaque liquid
containing dead WBCs and bacteria with general
debris from destroyed cells
 Chronic inflammation
 if the injurious agent persists then chronic
inflammation will ensue
 infln lasting many days, months or even years
 may lead to the formation of a chronic wound
Outcomes
 Chronic inflammation
 characterised by the dominating presence of
macrophages in the injured tissue
 are powerful defensive agents of the body
 but the toxins they release (including reactive oxygen
species) are injurious to the organism's own tissues as
well as invading agents
 almost always accompanied by tissue destruction
Resolution of inflammation
IR must be actively terminated
Failure to do so results in CI, and cellular
destruction
Resolution occurs by different mechanisms in
different tissues
 Short half-life of inflammatory mediators in vivo
 Production and release of TGF beta from MØs
 Downregulation of pro-inflammatory molecules, such
as leukotrienes
 Upregulation of anti-inflammatory molecules such as
the IL-1 receptor antagonist or the soluble TNF
receptor
Resolution of inflammation
Mechanisms of resolution in different tissues
 Apoptosis of pro-inflammatory cells
 Downregulation of receptor activity by high concns of
ligands
 IL-4 and IL-10 are cytokines responsible for
decreasing the production of TNF-a, IL-1, IL-6, and IL-
8
Resolution of inflammation
 Production of anti-inflammatory lipoxins
 Evidence now suggests that an active, coordinated
program of resolution initiates in the first few hours
after an IR begins
 After entering tissues, granulocytes promote the
switch of arachidonic acid–derived prostaglandins
and leukotrienes to lipoxins
 initiate the termination sequence
 Neutrophil recruitment thus ceases and apoptosis is
engaged
Resolution of inflammation
 Production of anti-inflammatory lipoxins
 These events coincide with the biosynthesis,
from omega-3 polyunsaturated fatty acids, of
resolvins and protectins
 critically shorten the period of neutrophil
infiltration by initiating apoptosis
 apoptotic neutrophils undergo phagocytosis by
MØs, leading to neutrophil clearance and release
of anti-inflammatory and reparative cytokines
such as TGF -β1
 anti-inflammatory program ends with the
departure of MØs thru the lymphatics
Outcomes of AI
Beneficial effects
 Beneficial effects of the fluid exudate are:
 Dilution of toxins
 Entry of antibodies
 Transport of drugs
 Fibrin formation: from exuded fibrinogen
 impede the movement of microorganisms
 trap them and so facilitate phagocytosis
 serves as a matrix for the formation of granulation tissue
 Delivery of nutrients and oxygen: essential for cells such
as neutrophils that have high metabolic activity
 Stimulation of immune response by drainage of this fluid
exudate into the lymphatics
4. acute Inflammation31.08.17 153 series.pptx

More Related Content

Similar to 4. acute Inflammation31.08.17 153 series.pptx

Lect 3-inflammation
Lect 3-inflammationLect 3-inflammation
Lect 3-inflammation
Mohanad Mohanad
 
chapter 3 inflammation.pptx
chapter 3 inflammation.pptxchapter 3 inflammation.pptx
chapter 3 inflammation.pptx
GeremuWendo
 
INFLAMMATION.pptx
INFLAMMATION.pptxINFLAMMATION.pptx
INFLAMMATION.pptx
ashharnomani
 
Inflammation Part 2
Inflammation Part 2Inflammation Part 2
Inflammation Part 2
hussamdr
 
Inflammation Part (2)
Inflammation Part  (2)Inflammation Part  (2)
Inflammation Part (2)
hussamdr
 
Inflammation....
Inflammation....Inflammation....
Inflammation....
ANIL KUMAR
 
lecture6inflammation-pptx-120913130832-phpapp01.pdf
lecture6inflammation-pptx-120913130832-phpapp01.pdflecture6inflammation-pptx-120913130832-phpapp01.pdf
lecture6inflammation-pptx-120913130832-phpapp01.pdf
DeviSneha1
 
acuteinflammationacuteinflammation.pptxacuteinflammation.pptx
acuteinflammationacuteinflammation.pptxacuteinflammation.pptxacuteinflammationacuteinflammation.pptxacuteinflammation.pptx
acuteinflammationacuteinflammation.pptxacuteinflammation.pptx
ssuser12303b
 
Acute and chronic inflammation
Acute and chronic inflammationAcute and chronic inflammation
Acute and chronic inflammation
Hamzeh AlBattikhi
 
Inflammation part 1
Inflammation part 1Inflammation part 1
Inflammation part 1
Ruchika Garg
 
Inflammation notes Pathophysiology
Inflammation  notes PathophysiologyInflammation  notes Pathophysiology
Inflammation notes Pathophysiology
BAVAMH
 
Inflammation 1
Inflammation 1Inflammation 1
Inflammation 1
sallamahmed1
 
Inflammation & cellular response
Inflammation & cellular responseInflammation & cellular response
Inflammation & cellular response
Muhammadasif909
 
Acute inflammation
Acute inflammationAcute inflammation
Acute inflammation
preetiagrawal79
 
Acute Inflammation process in biological system.pptx
Acute Inflammation process in biological system.pptxAcute Inflammation process in biological system.pptx
Acute Inflammation process in biological system.pptx
abdulqudus23
 
PROCESS OF INFLAMMATION B.PHARM 2ND SEM.pptx
PROCESS OF INFLAMMATION B.PHARM 2ND SEM.pptxPROCESS OF INFLAMMATION B.PHARM 2ND SEM.pptx
PROCESS OF INFLAMMATION B.PHARM 2ND SEM.pptx
subhamsourajit1
 
.INFLAMMATION 1.pptx
.INFLAMMATION 1.pptx.INFLAMMATION 1.pptx
.INFLAMMATION 1.pptx
GALIBOIBRAHIM
 
inflammation-180121165658.pdf
inflammation-180121165658.pdfinflammation-180121165658.pdf
inflammation-180121165658.pdf
DIVINEtourist
 
Inflammation and Healing (wound healing)
Inflammation and Healing (wound healing)Inflammation and Healing (wound healing)
Inflammation and Healing (wound healing)
Rajat Nanda
 

Similar to 4. acute Inflammation31.08.17 153 series.pptx (20)

Lect 3-inflammation
Lect 3-inflammationLect 3-inflammation
Lect 3-inflammation
 
chapter 3 inflammation.pptx
chapter 3 inflammation.pptxchapter 3 inflammation.pptx
chapter 3 inflammation.pptx
 
INFLAMMATION.pptx
INFLAMMATION.pptxINFLAMMATION.pptx
INFLAMMATION.pptx
 
Inflammation Part 2
Inflammation Part 2Inflammation Part 2
Inflammation Part 2
 
Inflammation Part (2)
Inflammation Part  (2)Inflammation Part  (2)
Inflammation Part (2)
 
Inflammation....
Inflammation....Inflammation....
Inflammation....
 
lecture6inflammation-pptx-120913130832-phpapp01.pdf
lecture6inflammation-pptx-120913130832-phpapp01.pdflecture6inflammation-pptx-120913130832-phpapp01.pdf
lecture6inflammation-pptx-120913130832-phpapp01.pdf
 
acuteinflammationacuteinflammation.pptxacuteinflammation.pptx
acuteinflammationacuteinflammation.pptxacuteinflammation.pptxacuteinflammationacuteinflammation.pptxacuteinflammation.pptx
acuteinflammationacuteinflammation.pptxacuteinflammation.pptx
 
Inflammation
Inflammation Inflammation
Inflammation
 
Acute and chronic inflammation
Acute and chronic inflammationAcute and chronic inflammation
Acute and chronic inflammation
 
Inflammation part 1
Inflammation part 1Inflammation part 1
Inflammation part 1
 
Inflammation notes Pathophysiology
Inflammation  notes PathophysiologyInflammation  notes Pathophysiology
Inflammation notes Pathophysiology
 
Inflammation 1
Inflammation 1Inflammation 1
Inflammation 1
 
Inflammation & cellular response
Inflammation & cellular responseInflammation & cellular response
Inflammation & cellular response
 
Acute inflammation
Acute inflammationAcute inflammation
Acute inflammation
 
Acute Inflammation process in biological system.pptx
Acute Inflammation process in biological system.pptxAcute Inflammation process in biological system.pptx
Acute Inflammation process in biological system.pptx
 
PROCESS OF INFLAMMATION B.PHARM 2ND SEM.pptx
PROCESS OF INFLAMMATION B.PHARM 2ND SEM.pptxPROCESS OF INFLAMMATION B.PHARM 2ND SEM.pptx
PROCESS OF INFLAMMATION B.PHARM 2ND SEM.pptx
 
.INFLAMMATION 1.pptx
.INFLAMMATION 1.pptx.INFLAMMATION 1.pptx
.INFLAMMATION 1.pptx
 
inflammation-180121165658.pdf
inflammation-180121165658.pdfinflammation-180121165658.pdf
inflammation-180121165658.pdf
 
Inflammation and Healing (wound healing)
Inflammation and Healing (wound healing)Inflammation and Healing (wound healing)
Inflammation and Healing (wound healing)
 

More from ByamugishaJames

2023 Sedative-Hypnotics D. Chanitos.N.ppt
2023 Sedative-Hypnotics D. Chanitos.N.ppt2023 Sedative-Hypnotics D. Chanitos.N.ppt
2023 Sedative-Hypnotics D. Chanitos.N.ppt
ByamugishaJames
 
1.2.6_NOTCH_signaling_pathway._corrected[1].pptx
1.2.6_NOTCH_signaling_pathway._corrected[1].pptx1.2.6_NOTCH_signaling_pathway._corrected[1].pptx
1.2.6_NOTCH_signaling_pathway._corrected[1].pptx
ByamugishaJames
 
203 MEGALOBLASTIC_ANAEMIAS lecture slides.ppt
203 MEGALOBLASTIC_ANAEMIAS lecture slides.ppt203 MEGALOBLASTIC_ANAEMIAS lecture slides.ppt
203 MEGALOBLASTIC_ANAEMIAS lecture slides.ppt
ByamugishaJames
 
Malaria in pregnancy_documentation 030759.pptx
Malaria in pregnancy_documentation 030759.pptxMalaria in pregnancy_documentation 030759.pptx
Malaria in pregnancy_documentation 030759.pptx
ByamugishaJames
 
UTI IN PREG in Obstetrics and Gynecology.pptx
UTI IN PREG in Obstetrics and Gynecology.pptxUTI IN PREG in Obstetrics and Gynecology.pptx
UTI IN PREG in Obstetrics and Gynecology.pptx
ByamugishaJames
 
PRE-ECLAMPSIA SUPERIMPOSED ON CHRONIC HTN.pptx
PRE-ECLAMPSIA SUPERIMPOSED ON CHRONIC HTN.pptxPRE-ECLAMPSIA SUPERIMPOSED ON CHRONIC HTN.pptx
PRE-ECLAMPSIA SUPERIMPOSED ON CHRONIC HTN.pptx
ByamugishaJames
 
Tocolytics medicines in Obstetrics and gynpptx
Tocolytics medicines in Obstetrics and gynpptxTocolytics medicines in Obstetrics and gynpptx
Tocolytics medicines in Obstetrics and gynpptx
ByamugishaJames
 
Sexually Transmitted Infections in gyn.pptx
Sexually Transmitted Infections in gyn.pptxSexually Transmitted Infections in gyn.pptx
Sexually Transmitted Infections in gyn.pptx
ByamugishaJames
 
OPERATIVE VAGINAL DELIVERY during labour.pptx
OPERATIVE VAGINAL DELIVERY during labour.pptxOPERATIVE VAGINAL DELIVERY during labour.pptx
OPERATIVE VAGINAL DELIVERY during labour.pptx
ByamugishaJames
 
OPERATIVE VAGINAL DELIVERY with instruments pptx
OPERATIVE VAGINAL DELIVERY with instruments pptxOPERATIVE VAGINAL DELIVERY with instruments pptx
OPERATIVE VAGINAL DELIVERY with instruments pptx
ByamugishaJames
 
ASSESSMENT OF FETAL WELL BEING in obstetric bms.pptx
ASSESSMENT OF FETAL WELL BEING in obstetric bms.pptxASSESSMENT OF FETAL WELL BEING in obstetric bms.pptx
ASSESSMENT OF FETAL WELL BEING in obstetric bms.pptx
ByamugishaJames
 
GROUP 17 IMMUNOPATHOLOGY.pptx course work
GROUP 17 IMMUNOPATHOLOGY.pptx course workGROUP 17 IMMUNOPATHOLOGY.pptx course work
GROUP 17 IMMUNOPATHOLOGY.pptx course work
ByamugishaJames
 
clinical microbiology presentation.pptx now
clinical microbiology presentation.pptx nowclinical microbiology presentation.pptx now
clinical microbiology presentation.pptx now
ByamugishaJames
 
Cell injury with best of the best activities
Cell injury with best of the best activitiesCell injury with best of the best activities
Cell injury with best of the best activities
ByamugishaJames
 
12.UBIQUITINATION.pptx
12.UBIQUITINATION.pptx12.UBIQUITINATION.pptx
12.UBIQUITINATION.pptx
ByamugishaJames
 
corrections.pptx
corrections.pptxcorrections.pptx
corrections.pptx
ByamugishaJames
 
MBBS intro CHEM path 1 ppt.ppt
MBBS intro CHEM path 1 ppt.pptMBBS intro CHEM path 1 ppt.ppt
MBBS intro CHEM path 1 ppt.ppt
ByamugishaJames
 
mat.pptx
mat.pptxmat.pptx
mat.pptx
ByamugishaJames
 
GRAND ROUND PRESENTION(0).pptx
GRAND ROUND PRESENTION(0).pptxGRAND ROUND PRESENTION(0).pptx
GRAND ROUND PRESENTION(0).pptx
ByamugishaJames
 
CASE PRESENTATION AIP (1).pptx
CASE PRESENTATION AIP (1).pptxCASE PRESENTATION AIP (1).pptx
CASE PRESENTATION AIP (1).pptx
ByamugishaJames
 

More from ByamugishaJames (20)

2023 Sedative-Hypnotics D. Chanitos.N.ppt
2023 Sedative-Hypnotics D. Chanitos.N.ppt2023 Sedative-Hypnotics D. Chanitos.N.ppt
2023 Sedative-Hypnotics D. Chanitos.N.ppt
 
1.2.6_NOTCH_signaling_pathway._corrected[1].pptx
1.2.6_NOTCH_signaling_pathway._corrected[1].pptx1.2.6_NOTCH_signaling_pathway._corrected[1].pptx
1.2.6_NOTCH_signaling_pathway._corrected[1].pptx
 
203 MEGALOBLASTIC_ANAEMIAS lecture slides.ppt
203 MEGALOBLASTIC_ANAEMIAS lecture slides.ppt203 MEGALOBLASTIC_ANAEMIAS lecture slides.ppt
203 MEGALOBLASTIC_ANAEMIAS lecture slides.ppt
 
Malaria in pregnancy_documentation 030759.pptx
Malaria in pregnancy_documentation 030759.pptxMalaria in pregnancy_documentation 030759.pptx
Malaria in pregnancy_documentation 030759.pptx
 
UTI IN PREG in Obstetrics and Gynecology.pptx
UTI IN PREG in Obstetrics and Gynecology.pptxUTI IN PREG in Obstetrics and Gynecology.pptx
UTI IN PREG in Obstetrics and Gynecology.pptx
 
PRE-ECLAMPSIA SUPERIMPOSED ON CHRONIC HTN.pptx
PRE-ECLAMPSIA SUPERIMPOSED ON CHRONIC HTN.pptxPRE-ECLAMPSIA SUPERIMPOSED ON CHRONIC HTN.pptx
PRE-ECLAMPSIA SUPERIMPOSED ON CHRONIC HTN.pptx
 
Tocolytics medicines in Obstetrics and gynpptx
Tocolytics medicines in Obstetrics and gynpptxTocolytics medicines in Obstetrics and gynpptx
Tocolytics medicines in Obstetrics and gynpptx
 
Sexually Transmitted Infections in gyn.pptx
Sexually Transmitted Infections in gyn.pptxSexually Transmitted Infections in gyn.pptx
Sexually Transmitted Infections in gyn.pptx
 
OPERATIVE VAGINAL DELIVERY during labour.pptx
OPERATIVE VAGINAL DELIVERY during labour.pptxOPERATIVE VAGINAL DELIVERY during labour.pptx
OPERATIVE VAGINAL DELIVERY during labour.pptx
 
OPERATIVE VAGINAL DELIVERY with instruments pptx
OPERATIVE VAGINAL DELIVERY with instruments pptxOPERATIVE VAGINAL DELIVERY with instruments pptx
OPERATIVE VAGINAL DELIVERY with instruments pptx
 
ASSESSMENT OF FETAL WELL BEING in obstetric bms.pptx
ASSESSMENT OF FETAL WELL BEING in obstetric bms.pptxASSESSMENT OF FETAL WELL BEING in obstetric bms.pptx
ASSESSMENT OF FETAL WELL BEING in obstetric bms.pptx
 
GROUP 17 IMMUNOPATHOLOGY.pptx course work
GROUP 17 IMMUNOPATHOLOGY.pptx course workGROUP 17 IMMUNOPATHOLOGY.pptx course work
GROUP 17 IMMUNOPATHOLOGY.pptx course work
 
clinical microbiology presentation.pptx now
clinical microbiology presentation.pptx nowclinical microbiology presentation.pptx now
clinical microbiology presentation.pptx now
 
Cell injury with best of the best activities
Cell injury with best of the best activitiesCell injury with best of the best activities
Cell injury with best of the best activities
 
12.UBIQUITINATION.pptx
12.UBIQUITINATION.pptx12.UBIQUITINATION.pptx
12.UBIQUITINATION.pptx
 
corrections.pptx
corrections.pptxcorrections.pptx
corrections.pptx
 
MBBS intro CHEM path 1 ppt.ppt
MBBS intro CHEM path 1 ppt.pptMBBS intro CHEM path 1 ppt.ppt
MBBS intro CHEM path 1 ppt.ppt
 
mat.pptx
mat.pptxmat.pptx
mat.pptx
 
GRAND ROUND PRESENTION(0).pptx
GRAND ROUND PRESENTION(0).pptxGRAND ROUND PRESENTION(0).pptx
GRAND ROUND PRESENTION(0).pptx
 
CASE PRESENTATION AIP (1).pptx
CASE PRESENTATION AIP (1).pptxCASE PRESENTATION AIP (1).pptx
CASE PRESENTATION AIP (1).pptx
 

Recently uploaded

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 

Recently uploaded (20)

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 

4. acute Inflammation31.08.17 153 series.pptx

  • 2. Inflammation  Describe the causes and mechanisms of acute and chronic inflammation  Describe the chemical mediators of inflammation  Understand the systemic effects of inflammation
  • 3. Inflammation local physiological response to tissue injury Not a disease, usu a manifestation of d’se beneficial effects:  destruction of invading microorganisms  walling off of an abscess cavity Prevent spread of infection
  • 4. Inflammation produce disease abscess in the brain: SOL Compress vital surrounding structure  fibrosis from CI may distort the tissues permanently alter their function purpose to localize and eliminate the causative agent  limit tissue injury and restore tissue to normality
  • 5. Inflammation classified according to its time course as:  acute inflammation  chronic inflammation
  • 6. Causes of acute inflammation  physical agents, e.g. trauma, heat, cold, ultraviolet light, radiation  irritant and corrosive chemical subst, e.g. acids, alkalis  Biological agents, e.g. pyogenic bacteria  immune-mediated hypersensitivity reactions, e.g. immune-mediated vasculitis, seasonal allergic rhinitis (hay fever)
  • 7.  Endogenous causes:  tissue necrosis, e.g. ischaemia resulting in a myocardial infarction  Circulation disorders: thrombosis, infarction, hemorrhage  Enzymes activation – e.g. acute pancreatitis  Metabolic products deposals – uric acid, urea Causes of acute inflammation
  • 8. Cardinal signs essential physical characteristics of AI formulated by Celsus 30 BC to AD 38 using the Latin words  rubor, calor, tumor and dolor rubor (redness) tumor (swelling) calor (heat) dolor (pain)  functio laesa, or loss of function  second century AD: Greek physician Galen
  • 9. are produced by a rapid vascular response and cellular events characteristic of AI main function of these events is to bring elements of the immune system to the site of injury prevent further tissue damage Cardinal Signs
  • 10. Early stages of AI In the early stages, oedema fluid, fibrin and neutrophil polymorphs accumulate in the extracellular spaces of the damaged tissue  presence of the cellular component: the neutrophil polymorph essential for a histological diagnosis AI response involves three processes:
  • 11. Vascular response 1. changes in vessel calibre: 2. increased vascular permeability and formation of the fluid exudate Cellular events 3. formation of the cellular exudate – emigration of the neutrophil polymorphs into the extravascular space Early stages of AI
  • 12. Vascular response Vasodilatation  BF to the capillary bed is normally limited by the precapillary sphincters  In AI vasodilatation occurs when the arterioles and precapillary sphincters relax results in increased blood flow to the injured area
  • 13. Increased vascular permeability  Endothelial intracellular proteins contract under the influence of chemical inflammatory mediators:  histamine, bradykinin, nitric oxide, C5a leukotriene B4 and platelet activating factor Endothelial contraction results in: increased fenestrations between endothelial cells increased permeability of vessels to plasma proteins Vascular response
  • 14. Increased vascular permeability Proteins leak out of the plasma into the interstitial spaces  includes circulating components: immunoglobulins and coagulation factors  decreases in the plasma oncotic pressure  escape of plasma proteins into interstitial S increases the colloid osmotic pressure there
  • 15. The Vascular Response  Phase I = vasoconstriction  momentary constriction of small blood vessels in the area  Vascular spasm begins very quickly (30 sec.) after the injury at it last a few minutes  mechanism of spasm is nervous – thru catecholamine liberated from sympatic nerves endings
  • 16. The Vascular Response  Phase II = active vasodilation  thru catabolism products that act thru receptors and directly stimulates vascular dilation – nervous mechanism  Dilation of arterioles and capillaries (redness = rubor)  Blood flow increases and gives pulsate sensation  Active hyperemia in skin territory and increased metabolism leads to higher local temperature (heat = calor)
  • 17. The Vascular Response  Phase III = passive vasodilation  Blood vessels in the affected area loose their reactivity to nervous and humoral stimuli and passive vasodilation occurs  Progressively fluid move into the tissues (increased vascular permeability and structural alteration of blood vessels) and cause swelling (tumor), pain, and impaired function
  • 18. The Vascular Response  Phase III = passive vasodilation  exudation of the fluid out of the capillaries and into the tissue spaces dilutes the offending agent  As fluid moves out of the capillaries, stagnation of flow and clotting of blood in the small capillaries occurs at the site of injury  This aids in localizing the spread of infectious microorganisms
  • 19. Inflammatory oedema capillary hydrostatic pressure increased much more fluid leaves the vessels than is returned to them  net escape of protein-rich fluid is called exudation  called the fluid exudate
  • 20. combined increase in hydrostatic pressure and the decreased oncotic pressure (from leakage of proteins into ECS) causes net fluid movement from plasma into tissues this is inflammatory oedema Inflammatory oedema
  • 21. Advantages of I oedema Fluid increase in the damaged tissue dilutes and modifies the action of toxins Protein levels increase in the tissue—these include protective antibodies and fibrin Non-specific antibodies act as opsonins for neutrophil mediated phagocytosis and function to neutralize toxins
  • 22. If the antigen is coated with antibody or complement, its adherence is increased because of binding to complement This process of enhanced binding of an antigen caused by antibody or complement is called opsonization Advantages of I oedema
  • 24. Advantages of I oedema formation of a fibrin net acts as a scaffold for inflammatory cells  prevent the spread of microorganisms Circulation of the exudate into the lymphatic system assists in antigen presentation  helps mount a specific immune response
  • 25. Cellular events Formation of the cellular exudate  accumulation of neutrophils within the ECS diagnostic histological feature of AI  Neutrophils pass between endothelial cell junctions and invade damaged tissue to combat the effects of injury  The movement of leucocytes out of the vessel lumen is termed extravasation
  • 26. Extravasation achieved in five stages 1. Margination to the plasmatic zone This is assisted by the slowing of the blood 2. ‘Rolling’ of leucocytes due to the repeated formation and destruction of transient adhesions with the endothelium
  • 27. 3. Adhesion: ‘pavementing’—leucocytes eventually firmly adhere to the endothelium due to the interaction of paired molecules on the leucocyte and endothelial cell surface, e.g. β2- integrin and ICAM-1 4. Transmigration: diapedesis—leucocytes pass between the endothelial cell junctions, through the vessel wall into tissue spaces Extravasation
  • 28. 5. Chemotaxis— After exiting the circulation, neutrophils move in the tissues toward the site of injury by a process called chemotaxis neutrophils migrate are possibly activated by chemical substances: chemotaxins released at sites of tissue injury thought to be leukotrienes, complement components and bacterial products Extravasation
  • 29.  Steps in neutrophil emigration  Neutrophils  (1) marginate into the plasmatic zone  (2) adhere to endothelial cells  (3) pass between endothelial cells  (4) pass through the basal lamina and migrate into the adventitia
  • 30. Phagocytosis and intracellular killing predominant cell type of AI is the neutrophil Lymphocytes, plasma cells and MØs are the cells found in CI
  • 31. Neutrophils and monocytes ingest debris and foreign particles at the site Cellular pseudopodia engulf the foreign particle and fuse  phagocytic vacuole or phagosome Phagocytosis is assisted by opsonization with immunoglobulins and complement components Phagocytosis and intracellular killing
  • 32.  Phagocytosis of foreign particle by leucocyte  (A) Attachment of foreign particle  (B) Pseudopodia engulfing particle  (C) and (D) Incorporation within the cell in a vacuole: phagosome
  • 33. Following phagocytosis, leucocytes attempt to destroy phagocytosed material:  discharge of lysosomal enzymes into the phagosome  oxygen-dependent mechanisms: H2O2, O2−, •OH  oxygen-independent mechanisms: lactoferrin, lysozyme and hydrolases Phagocytosis and intracellular killing
  • 34.  actions of neutrophils in AI process  events mediated by:  Selectins  ICAM-1: intercellular adhesion molecule 1  CD31  C5a and leukotriene B4  C3b and IgG  Myeloperoxidase, lysozyme
  • 35. Chemical mediators of inflammation Several different inflammatory mediator systems interact to produce inflammation No chemical mediator alone can be entirely responsible for any single feature of the IR Regulatory mechanisms exist in all mediator systems
  • 36. Chemical mediators of inflammation chemicals called endogenous chemical mediators, cause:  vasodilatation  emigration of neutrophils  chemotaxis  increased vascular permeability  itching and pain
  • 37. Endogenous chemical mediators of the acute IR
  • 38. TNF-a and IL-1 are responsible for  fever and the release of stress hormones norepinephrine, vasopressin, activation of the renin-angiotensin-aldosterone system  synthesis of IL-6, IL-8, and interferon gamma Cytokines, esp IL-6, stimulate the release of acute-phase reactants such as C-reactive protein (CRP) Chemical mediators of inflammation
  • 39. The proinflammatory interleukins either function directly on tissue work via secondary mediators to activate:  the coagulation cascade  complement cascade  the release of nitric oxide, platelet-activating factor, prostaglandins, and leukotrienes Chemical mediators of inflammation
  • 40.  Complement fragments and cytokines  stimulates chemotaxis of neutrophils, eosinophils and monocytes  C3a, C5a increase vascular permeability;  Cytokines  Interleukins (IL1, IL 6, IL8) Stimulates the chemotaxis, degranulation of neutrophils and their phagocytic activity Induce extravascularization of granulocytes Fever  Tumor necrosis factor (TNF) and IL 8 Leukocytosis Fever Stimulates prostaglandins production Chemical mediators of inflammation
  • 41. Prostaglandins lipid soluble molecules derived from arachidonic acid, a fatty acid liberated from cell membrane phospholipids, through the cyclooxygenase pathway contribute to vasodilation, capillary permeability, and the pain and fever that accompany inflammation Chemical mediators of inflammation
  • 42. Stable prostaglandins: PGE1 and PGE2 induce inflammation potentiate the effects of histamine and other inflammatory mediators: cause the dilation of precapillary arterioles lower the blood pressure modulates receptors activity affect the phagocytic activity of WBC prostaglandin thromboxane A2 promotes platelet aggregation and vasoconstriction Chemical mediators of inflammation
  • 43. Leukotrienes are formed from arachidonic acid thru the lipoxygenase pathway Histamine and leukotrienes are complementary in action Histamine is produced rapidly and transiently while the more potent leukotrienes are being synthesized Chemical mediators of inflammation
  • 44. Leukotrienes  C4 and D4 are recognized as the primary components of the slow reacting substance of anaphylaxis (SRS-A) causes slow and sustained constriction of the bronchioles Leukotrienes affect permeability of the postcapillary venules adhesion properties of endothelial cells stimulates the chemotaxis extravascularization of neutrophils, eosinophils, and monocytes Chemical mediators of inflammation
  • 46. Histamine  found in high concn in platelets, basophils, and mast cells  Causes dilation and increased permeability of capillaries: causes dilatation of precapillary arterioles contraction of endothelial cells dilation of postcapillary venules  It acts through H1 receptors Chemical mediators of inflammation
  • 47. Platelet-activating factor (PAF)  generated from a lipid complex stored in cell membranes  affects a variety of cell types and induces platelet aggregation  activates neutrophils and is a potent eosinophil chemoattractant  contributes to extravascularization of plasma proteins and so, to edema Chemical mediators of inflammation
  • 48. Plasma Proteases: consist of:  Kinins Bradykinin - causes increased capillary permeability: (implicated in hyperthermia and redness) and pain  Clotting factors clotting system contributes to the vascular phase of inflammation mainly thru fibrin peptides that are formed during the final steps of the clotting process Chemical mediators of inflammation
  • 49. Metabolic changes in inflammation Protein metabolism  Is increased – cell destruction, metabolic products lead o increased osmotic pressure in interstitial space which attracts water and contributes to edema (swelling = tumor)  metabolic changes: including skeletal muscle catabolism, provide amino acids that can be used in the immune response and for tissue repair Glucose metabolism  Anaerobe utilization of glucose is increased because of hypoxia with increased formation of lactic and pyruvic acid
  • 50. Metabolic changes in inflammation Lipid metabolism  Increased formation of ketons and fatty acids Mineral metabolism  Increased extracellular K+ concentration Acid – base balance  Metabolic acidosis (ketons, lactic acid)
  • 51. Systemic manifestations of inflammation  IR remains confined to a localized area  local injury can result in prominent systemic manifestations  inflammatory mediators are released into the circulation  most prominent systemic manifestations are:  acute phase response  Alterations in WBC count  leukocytosis or leukopenia  Fever  Sepsis and septic shock: systemic inflammatory response  severe systemic manifestations of inflammation
  • 52. The acute phase response  Usually begins within hours or days of the onset of inflammation or infection  Includes:  changes in the concns of plasma proteins - liver dramatically increases the synthesis of acute-phase proteins such as fibrinogen and C-reactive protein  increased erythrocyte sedimentation rate  fever  increased numbers of leukocytes  skeletal muscle catabolism  negative nitrogen balance
  • 53. The acute phase response  responses are generated after the release of the cytokines, IL-1, IL-6, and TNF:  cytokines affect the thermoregulatory center in the hypothalamus to produce fever  IL-1 and other cytokines induce an increase in the number and immaturity of circulating neutrophils by stimulating their production in the bone marrow  Lethargy a common feature of the acute-phase response results from the effects of IL-1 and TNF on the CNS
  • 54. Outcomes of AI  Resolution  complete restoration of the inflamed tissue back to a normal status  Inflammatory measures such as vasodilation, chemical production, and leukocyte infiltration cease, and damaged parenchymal cells regenerate  limited or short lived inflammation: usual outcome  Fibrosis  Large amounts of tissue destruction, or damage in tissues unable to regenerate  Fibrous scarring occurs in these areas of damage  forming a scar composed primarily of collagen scar will not contain any specialized structures  parenchymal cells, hence functional impairment may occur
  • 55. Outcomes  Abscess formation  A cavity is formed containing pus, an opaque liquid containing dead WBCs and bacteria with general debris from destroyed cells  Chronic inflammation  if the injurious agent persists then chronic inflammation will ensue  infln lasting many days, months or even years  may lead to the formation of a chronic wound
  • 56. Outcomes  Chronic inflammation  characterised by the dominating presence of macrophages in the injured tissue  are powerful defensive agents of the body  but the toxins they release (including reactive oxygen species) are injurious to the organism's own tissues as well as invading agents  almost always accompanied by tissue destruction
  • 57. Resolution of inflammation IR must be actively terminated Failure to do so results in CI, and cellular destruction Resolution occurs by different mechanisms in different tissues  Short half-life of inflammatory mediators in vivo  Production and release of TGF beta from MØs  Downregulation of pro-inflammatory molecules, such as leukotrienes  Upregulation of anti-inflammatory molecules such as the IL-1 receptor antagonist or the soluble TNF receptor
  • 58. Resolution of inflammation Mechanisms of resolution in different tissues  Apoptosis of pro-inflammatory cells  Downregulation of receptor activity by high concns of ligands  IL-4 and IL-10 are cytokines responsible for decreasing the production of TNF-a, IL-1, IL-6, and IL- 8
  • 59. Resolution of inflammation  Production of anti-inflammatory lipoxins  Evidence now suggests that an active, coordinated program of resolution initiates in the first few hours after an IR begins  After entering tissues, granulocytes promote the switch of arachidonic acid–derived prostaglandins and leukotrienes to lipoxins  initiate the termination sequence  Neutrophil recruitment thus ceases and apoptosis is engaged
  • 60. Resolution of inflammation  Production of anti-inflammatory lipoxins  These events coincide with the biosynthesis, from omega-3 polyunsaturated fatty acids, of resolvins and protectins  critically shorten the period of neutrophil infiltration by initiating apoptosis  apoptotic neutrophils undergo phagocytosis by MØs, leading to neutrophil clearance and release of anti-inflammatory and reparative cytokines such as TGF -β1  anti-inflammatory program ends with the departure of MØs thru the lymphatics
  • 62. Beneficial effects  Beneficial effects of the fluid exudate are:  Dilution of toxins  Entry of antibodies  Transport of drugs  Fibrin formation: from exuded fibrinogen  impede the movement of microorganisms  trap them and so facilitate phagocytosis  serves as a matrix for the formation of granulation tissue  Delivery of nutrients and oxygen: essential for cells such as neutrophils that have high metabolic activity  Stimulation of immune response by drainage of this fluid exudate into the lymphatics